Related references
Note: Only part of the references are listed.[1,2,4]Triazolo[1,5-a]pyrimidine derivative (Mol-5) is a new NS5-RdRp inhibitor of DENV2 proliferation and DENV2-induced inflammation
Yi-hong Wan et al.
ACTA PHARMACOLOGICA SINICA (2020)
Synthesis, molecular docking and antimicrobial activity of new fused pyrimidine and pyridine derivatives
Mohamed A. A. Radwan et al.
BIOORGANIC CHEMISTRY (2020)
Dysregulation of de novo nucleotide biosynthetic pathway enzymes in cancer and targeting opportunities
Alyncia D. Robinson et al.
CANCER LETTERS (2020)
Resveratrol slows the tumourigenesis of pancreatic cancer by inhibiting NFκB activation
Weikun Qian et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Synthesis and biological activity of 2-cyanoacrylamide derivatives tethered to imidazopyridine as TAK1 inhibitors
Seok Jong Kang et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Colletopeptides A-D, Anti-inflammatory Cyclic Tridepsipeptides from the Plant Endophytic Fungus Colletotrichum sp. S8
Li Feng et al.
JOURNAL OF NATURAL PRODUCTS (2019)
Natural cyclopeptide RA-V inhibits the NF-κB signaling pathway by targeting TAK1
Zhe Wang et al.
CELL DEATH & DISEASE (2018)
Discovery of Novel Phosphodiesterase-2A Inhibitors by Structure-Based Virtual Screening, Structural Optimization, and Bioassay
Chen Zhang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2017)
Discovery of a potent and highly selective transforming growth factor β receptor-associated kinase 1 (TAK1) inhibitor by structure based drug design (SBDD)
Terushige Muraoka et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Isatin Derived Spirocyclic Analogues with α-Methylene-γ-butyrolactone as Anticancer Agents: A Structure-Activity Relationship Study
Sandeep Rana et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Natural Products as Sources of New Drugs from 1981 to 2014
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2016)
TAK1 inhibitor NG25 enhances doxorubicin-mediated apoptosis in breast cancer cells
Zhenyu Wang et al.
SCIENTIFIC REPORTS (2016)
Optimization of peptidomimetic boronates bearing a P3 bicyclic scaffold as proteasome inhibitors
Valeria Troiano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
g_mmpbsa-A GROMACS Tool for High-Throughput MM-PBSA Calculations
Rashmi Kumari et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2014)
Mechanism and In Vitro Pharmacology of TAK1 Inhibition by (5Z)-7-Oxozeaenol
Jiaquan Wu et al.
ACS CHEMICAL BIOLOGY (2013)
g_contacts: Fast contact search in bio-molecular ensemble data
Christian Blau et al.
COMPUTER PHYSICS COMMUNICATIONS (2013)
Potent Proteasome Inhibitors Derived from the Unnatural cis-Cyclopropane Isomer of Belactosin A: Synthesis, Biological Activity, and Mode of Action
Shuhei Kawamura et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Plant cyclopeptide RA-V kills human breast cancer cells by inducing mitochondria-mediated apoptosis through blocking PDK1-AKT interaction
Xian-Ying Fang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Dimer-specific regulatory mechanisms within the NF-κB family of transcription factors
Stephen T. Smale
IMMUNOLOGICAL REVIEWS (2012)
Targeting of TAK1 in inflammatory disorders and cancer
Hiroaki Sakurai
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases
Andrew W. Tai et al.
ANALYTICAL BIOCHEMISTRY (2011)
Curaxins: Anticancer Compounds that Simultaneously Suppress NF-κB and Activate p53 by Targeting FACT
Alexander V. Gasparian et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Inhibiting NF-kappa B activation by small molecules as a therapeutic strategy
Subash C. Gupta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Rubiyunnanins C-H, cytotoxic cyclic hexapeptides from Rubia yunnanensis inhibiting nitric oxide production and NF-κB activation
Jun-Ting Fan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Dauricine Induces Apoptosis, Inhibits Proliferation and Invasion Through Inhibiting NF-κB Signaling Pathway in Colon Cancer Cells
Zhengfeng Yang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility
Garrett M. Morris et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2009)
Shared principles in NF-κB signaling
Matthew S. Hayden et al.
CELL (2008)
A novel class of potent NF-icB signaling inhibitors
Johann Leban et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Automatic atom type and bond type perception in molecular mechanical calculations
Junmei Wang et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
The evolving role of natural products in drug discovery
FE Koehn et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Development and testing of a general amber force field
JM Wang et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Discovery of quinazolines as a novel structural class of potent inhibitors of NF-κB activation
M Tobe et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2003)
Share Paper
